Does new permanent pacemaker implantation after transcatheter aortic valve replacement affect morbidity, mortality, and health care costs?
Patients undergoing transcatheter aortic valve replacement
New permanent pacemaker implantation
No new permanent pacemaker implantation
Morbidity, mortality, and cumulative health care costshard clinical
New permanent pacemaker implantation after TAVR is associated with increased long-term morbidity and mortality, though without a significant difference in post-discharge cumulative healthcare costs.
New permanent pacemaker implantation after transcatheter aortic valve replacement was associated with significantly greater morbidity and mortality at long-term follow-up. However, this did not translate to a difference in cumulative health care costs after hospital discharge.
Building similarity graph...
Analyzing shared references across papers
Loading...
Talal Aljabbary
Interventional / Structural Cardiology
Feng Qiu
Twitter (United States)
Shannon Masih
St. Michael's Hospital
JAMA Network Open
University of Toronto
Université Laval
Sunnybrook Health Science Centre
Building similarity graph...
Analyzing shared references across papers
Loading...
Aljabbary et al. (Fri,) studied this question.
synapsesocial.com/papers/69d572e375589c71d767e8d1 — DOI: https://doi.org/10.1001/jamanetworkopen.2018.0088
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: